ICU MEDICAL INC/DE - Common Stock (ICUI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ICUI on Nasdaq
Underlying class
Common Stock
Shares outstanding
24,701,460
Price per share
$142.68
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
25,798,861
Total reported value
$3,091,750,564
% of total 13F portfolios
0%
Share change
+719,121
Value change
+$75,847,661
Number of holders
267
Price from insider filings
$142.68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ICU MEDICAL INC/DE - Common Stock (ICUI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% 0% $326,429,794 +$272,229 2,470,146 +0.08% JANUS HENDERSON GROUP PLC 30 Jun 2025

As of 30 Sep 2025, 267 institutional investors reported holding 25,798,861 shares of ICU MEDICAL INC/DE - Common Stock (ICUI). This represents 104% of the company’s total 24,701,460 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ICU MEDICAL INC/DE - Common Stock (ICUI) together control 86% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 3,521,591 -1.2% 0.01% $422,450,057
VANGUARD GROUP INC 11% 2,624,991 -1.3% 0% $314,893,920
JANUS HENDERSON GROUP PLC 10% 2,473,536 +0.14% 0.14% $296,724,701
FULLER & THALER ASSET MANAGEMENT, INC. 5.6% 1,385,155 -0.35% 0.56% $166,163,180
MILLENNIUM MANAGEMENT LLC 4.4% 1,089,017 +173% 0.1% $130,638,479
STATE STREET CORP 3.7% 917,125 -1.2% 0% $110,018,315
DIMENSIONAL FUND ADVISORS LP 3.5% 872,993 +17% 0.02% $104,718,042
AMERIPRISE FINANCIAL INC 3.3% 803,542 +34% 0.02% $96,393,067
SCHRODER INVESTMENT MANAGEMENT GROUP 3.2% 796,704 +25% 0.07% $93,246,236
JPMORGAN CHASE & CO 2.7% 676,370 -11% 0.01% $81,137,344
River Road Asset Management, LLC 2.6% 651,156 -0.05% 0.88% $78,112,674
NEUBERGER BERMAN GROUP LLC 2.6% 641,946 +24% 0.06% $77,007,842
GEODE CAPITAL MANAGEMENT, LLC 2.4% 593,328 -1.8% 0% $71,185,268
MORGAN STANLEY 2.3% 565,186 +5% 0% $67,799,797
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.8% 432,766 +31% 0.34% $51,915,023
UBS Group AG 1.6% 386,555 +240% 0.01% $46,371,138
NORTHERN TRUST CORP 1.6% 385,895 -0.7% 0.01% $46,291,963
FMR LLC 1.5% 365,279 -19% 0% $43,818,838
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 307,232 +0.24% 0.01% $36,855,551
FEDERATED HERMES, INC. 1.2% 290,292 +56% 0.06% $34,823,429
MACQUARIE GROUP LTD 1.2% 285,791 +2.2% 0.04% $34,283,000
SEGALL BRYANT & HAMILL, LLC 1.1% 280,521 -5.1% 0.45% $33,651,299
GOLDMAN SACHS GROUP INC 1.1% 278,714 +39% 0% $33,434,471
Quantinno Capital Management LP 1% 252,449 +87% 0.08% $30,283,782
BANK OF AMERICA CORP /DE/ 1% 249,663 -20% 0% $29,949,573

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 57,118 $8,201,943 +$814,754 $142.68 12
2025 Q3 25,798,861 $3,091,750,564 +$75,847,661 $119.96 267
2025 Q2 25,082,538 $3,314,262,195 +$97,749,003 $132.15 273
2025 Q1 24,312,384 $3,381,985,980 +$22,039,356 $138.86 281
2024 Q4 24,213,401 $3,756,909,626 -$58,516,049 $155.17 285
2024 Q3 24,553,720 $4,467,331,041 +$76,905,236 $182.22 287
2024 Q2 23,790,393 $2,825,088,620 +$149,203,804 $118.75 256
2024 Q1 22,617,632 $2,427,031,471 +$116,351,455 $107.32 251
2023 Q4 21,600,686 $2,154,454,730 -$89,807,764 $99.74 241
2023 Q3 22,298,221 $2,653,725,397 -$35,106,953 $119.01 215
2023 Q2 22,249,048 $3,964,270,637 -$74,461,498 $178.19 227
2023 Q1 22,697,462 $3,743,979,121 +$70,541,615 $164.96 231
2022 Q4 22,295,759 $3,511,926,675 +$39,756,872 $157.48 241
2022 Q3 22,630,155 $3,408,280,475 -$240,293,324 $150.60 231
2022 Q2 21,624,606 $3,556,543,462 +$100,918,106 $164.39 246
2022 Q1 20,908,251 $4,657,377,472 +$150,898,618 $222.64 282
2021 Q4 20,185,157 $4,789,939,188 +$34,827,837 $237.34 288
2021 Q3 19,964,154 $4,660,018,823 -$53,955,352 $233.38 272
2021 Q2 20,303,486 $4,177,920,660 +$50,461,509 $205.80 266
2021 Q1 20,080,347 $4,125,473,068 +$114,043,017 $205.44 277
2020 Q4 19,530,259 $4,188,765,735 +$40,730,429 $214.49 273
2020 Q3 19,335,530 $3,533,762,551 -$33,121,822 $182.76 273
2020 Q2 19,504,752 $3,594,237,202 +$747,251 $184.31 285
2020 Q1 19,503,919 $3,933,938,959 -$44,075,766 $201.77 264
2019 Q4 19,759,409 $3,697,111,618 +$109,354,567 $187.12 262
2019 Q3 19,175,080 $3,060,005,447 -$169,056,479 $159.60 246
2019 Q2 19,515,114 $4,913,528,084 +$236,037,417 $251.91 266
2019 Q1 18,741,811 $4,485,031,238 -$83,298,148 $239.33 285
2018 Q4 19,044,665 $4,373,102,047 +$710,058,537 $229.63 286
2018 Q3 15,694,440 $4,437,405,702 +$195,341,135 $282.75 344
2018 Q2 15,060,933 $4,422,798,114 +$58,940,996 $293.65 339
2018 Q1 14,873,366 $3,747,945,182 -$171,234,588 $252.40 286
2017 Q4 15,562,889 $3,361,849,633 -$74,371,611 $216.00 254
2017 Q3 15,896,325 $2,954,582,018 +$34,239,606 $185.85 224
2017 Q2 15,722,627 $2,705,181,843 +$285,356,060 $172.50 225
2017 Q1 15,533,117 $2,371,867,645 +$304,529,806 $152.70 229
2016 Q4 15,216,010 $2,241,820,263 +$103,756,391 $147.35 243
2016 Q3 14,507,458 $1,832,998,453 +$26,003,941 $126.38 226
2016 Q2 14,325,038 $1,615,346,710 -$1,974,085 $112.75 215
2016 Q1 14,374,065 $1,496,358,514 +$37,499,197 $104.10 211
2015 Q4 14,089,884 $1,588,866,427 -$25,778,655 $112.78 223
2015 Q3 14,320,264 $1,564,865,155 -$33,583,970 $109.50 205
2015 Q2 14,680,545 $1,404,322,180 +$22,278,781 $95.66 194
2015 Q1 14,454,758 $1,346,125,061 +$33,464,178 $93.14 185
2014 Q4 14,150,736 $1,159,233,343 +$12,688,058 $81.90 192
2014 Q3 14,295,859 $917,513,365 -$3,357,133 $64.18 171
2014 Q2 14,359,564 $873,192,036 +$5,449,682 $60.81 161
2014 Q1 14,274,842 $854,737,039 +$41,894,072 $59.88 166